Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV

References

• World Health Organization. HIV/AIDS; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aidss . Accessed September 3, 2022.
   Google Scholar
• World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Web Annex 1: key data at a glance; 2021.
   Google Scholar
• Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2015–2019. HIV Surveillance Supplemental Report; 2021.
   Google Scholar
• Trickey A, May MT, Vehreschild -J-J; Antiretroviral Therapy Cohort C. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–e356. doi:10.1016/S2352-3018(17)30066-8
   PubMed Web of Science ®Google Scholar
• Greene M, Justice AC, Lampiris HW, Valcour V. Management of human immunodeficiency virus infection in advanced age. JAMA. 2013;309:1397–1405. doi:10.1001/jama.2013.2963
   PubMed Web of Science ®Google Scholar
• Schouten J, Wit FW, Stolte IG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59:1787–1797. doi:10.1093/cid/ciu701
   PubMed Web of Science ®Google Scholar
• Milic J, Russwurm M, Cerezales Calvino A, Brañas F, Sánchez-Conde M, Guaraldi G. European cohorts of older HIV adults: POPPY, AGE(h)IV, GEPPO, COBRA and FUNCFRAIL. Eur Geriatr Med. 2019;10:247–257. doi:10.1007/s41999-019-00170-8
   PubMed Web of Science ®Google Scholar
• Ergin HE, Inga EE, Maung TZ, Javed M, Khan S. HIV, antiretroviral therapy and metabolic alterations: a review. Cureus. 2020;12:e8059. doi:10.7759/cureus.8059
   PubMed Web of Science ®Google Scholar
• da Cunha J, Maselli LM, Stern AC, Spada C, Bydlowski SP. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: old and new drugs. World J Virol. 2015;4(2):56–77. doi:10.5501/wjv.v4.i2.56
   PubMedGoogle Scholar
• d’Ettorre G, Ceccarelli G, Pavone P, et al. What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther. 2016;13:21. doi:10.1186/s12981-016-0105-z
   PubMed Web of Science ®Google Scholar
• Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–543.
   PubMedGoogle Scholar
• Ahmed A, Abdulelah Dujaili J, Rehman IU, et al. Effect of pharmacist care on clinical outcomes among people living with HIV/AIDS: a systematic review and meta-analysis. Res Social Adm Pharm. 2022;18(6):2962–2980. doi:10.1016/j.sapharm.2021.07.020
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Martínez-Sesmero JM, Lázaro-López A, Sánchez-Rubio J, Navarro-Aznárez H, DeMiguel-Cascón M. Development of a risk stratification model for pharmaceutical care in HIV patients. Farm Hosp. 2017;41:346–356. doi:10.7399/fh.2017.41.3.10655
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Calleja-Hernandez MA, Robustillo-Cortes MLA. A new pharmaceutical care concept: more capable, motivated, and timely. Hosp Pharm. 2019;54:348–350. doi:10.1177/0018578719867657
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Robustillo-Cortés MA, Manzano García M, Almeida-González CV. Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients. Rev Esp Quimioter. 2019;32:40–49. doi:10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Robustillo-Cortes MLA, Navarro-Ruiz A, et al. Clinical impact of the capacity-motivation-opportunity pharmacist-led intervention in people living with HIV in Spain, 2019–2020. J Multidiscip Healthc. 2022;15:1203–1211. doi:10.2147/jmdh.S361305
   PubMed Web of Science ®Google Scholar
• Cantillana-Suárez MG, Robustillo-Cortés MLA, Gutiérrez-Pizarraya A, Morillo-Verdugo R. Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study. Eur J Hosp Pharm. 2021;28(e1):e157–e163. doi:10.1136/ejhpharm-2020-002330
   PubMedGoogle Scholar
• Morillo-Verdugo R, Vélez-Díaz-Pallarés M, Fernández-Pacheco García-Valdecasas M, Fernández-Espínola S, Sánchez-Rubio Ferrández J, Navarro-Ruiz A. Application of the CMO methodology to the improvement of primary adherence to concomitant medication in people living with-HIV. The PRICMO Project. Farm Hosp. 2021;45:247–252.
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Robustillo-Cortes MLA, Martin-Conde MT, et al. Effect of a structured pharmaceutical care intervention versus usual care on cardiovascular risk in HIV patients on antiretroviral therapy: INFAMERICA study. Ann Pharmacother. 2018;52:1098–1108. doi:10.1177/1060028018778045
   PubMed Web of Science ®Google Scholar
• Cantillana-Suárez MG, Manzano-García M, Robustillo-Cortés MLA, Morillo-Verdugo R. Evaluation of HIV+ patients experience with pharmaceutical care based on AMO-methodology. Farm Hosp. 2018;42:200–203. doi:10.7399/fh.10947
   PubMed Web of Science ®Google Scholar
• Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Vlasses PH. Education of manpower for future pharmaceutical care and research. Drug Intell Clin Pharm. 1988;22:800–803. doi:10.1177/106002808802201018
   PubMedGoogle Scholar
• Schafer JJ, Gill TK, Sherman EM, McNicholl IR, Hawkins B. ASHP guidelines on pharmacist involvement in HIV care. Am J Health Syst Pharm. 2016;73(7):468–494. doi:10.2146/ajhp150623
   PubMed Web of Science ®Google Scholar
• Mira JJ, Nuño-Solinís R, Guilabert-Mora M, et al. Development and validation of an instrument for assessing patient experience of chronic illness care. Int J Integr Care. 2016;16:13. doi:10.5334/ijic.2443
   PubMed Web of Science ®Google Scholar
• Mendoza-Aguilera M, Ferrando-Piqueres R, Martín TA, et al. Adherencia al tratamiento antirretroviral en pacientes VIH: todavía queda mucho por hacer. Ibero Latin Am J Health Syst Pharm. 2018;28:203–210.
   Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi:10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Monje-Agudo P, Borrego-Izquierdo Y, Robustillo-Cortés Mde L, Jiménez-Galán R, Almeida-González CV, Morillo-Verdugo RA. Encuesta de valoración de la satisfacción de los pacientes con la Atención Farmacéutica recibida en las consultas de Farmacia hospitalaria [Design and validation of a satisfaction survey with pharmaceutical care received in hospital pharmacy consultation]. Farm Hosp. 2015;39:152–156. Spanish. doi:10.7399/fh.2015.39.3.8366
   PubMedGoogle Scholar
• Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One. 2012;7:e32190. doi:10.1371/journal.pone.0032190
   PubMed Web of Science ®Google Scholar
• Ho IS, Holloway A, Stenhouse R. What do HIV-positive drug users’ experiences tell us about their antiretroviral medication-taking? An international integrated literature review. Addiction. 2020;115(4):623–652. doi:10.1111/add.14857
   PubMed Web of Science ®Google Scholar
• Hernández Arroyo MJ, Cabrera Figueroa SE, Sepúlveda Correa R, Valver de Merino Mde L, Iglesias Gómez A, Domínguez-Gil Hurlé A. Impact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: a 5-year study. Patient Prefer Adherence. 2013;7:729–739. doi:10.2147/ppa.S47519
   PubMed Web of Science ®Google Scholar
• McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E, Pharmacist-Led A. Program to evaluate and reduce polypharmacy and potentially inappropriate prescribing in older HIV-positive patients. Pharmacotherapy. 2017;37(12):1498–1506. doi:10.1002/phar.2043
   PubMed Web of Science ®Google Scholar
• Morillo-Verdugo R, Aguilar Pérez T, Gimeno-Gracia M, Rodríguez-González C, Robustillo-Cortes MLA. Simplification and multidimensional adaptation of the stratification tool for pharmaceutical care in people living with HIV. Ann Pharmacother. 2022;10600280221096759. doi:10.1177/10600280221096759
   Web of Science ®Google Scholar